Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2350 of 2529 entries
View as:

Dose Finding Study for QAW039 in Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01437735 Org: User:
Start: 08/31/11 End: 11/30/13 Due: 11/30/14

Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04795466 Org: User:
Start: 10/28/21 End: 03/07/24 Due: 03/07/25

Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

Phase: N/A Priority: Normal
NCT ID: NCT06659393 Org: User:
Start: 12/19/24 End: 11/30/27 Due: 11/30/28

MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

Phase: N/A Priority: Normal
NCT ID: NCT00284921 Org: User:
Start: 04/30/04 End: - Due: -

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET

Phase: N/A Priority: Normal
NCT ID: NCT01374451 Org: User:
Start: 06/30/11 End: 02/28/15 Due: 02/28/16

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT04264819 Org: User:
Start: 12/14/20 End: 05/10/23 Due: 05/10/24

Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.

Phase: N/A Priority: Normal
NCT ID: NCT02049450 Org: User:
Start: 05/28/14 End: 04/12/16 Due: 04/12/17

The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00468260 Org: User:
Start: 05/31/07 End: - Due: -

Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.

Phase: N/A Priority: Normal
NCT ID: NCT02140411 Org: User:
Start: 04/25/15 End: 12/21/16 Due: 12/21/17

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Phase: N/A Priority: Normal
NCT ID: NCT01735955 Org: User:
Start: 03/29/13 End: 07/07/23 Due: 07/07/24

Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population

Phase: N/A Priority: Normal
NCT ID: NCT02795416 Org: User:
Start: 06/30/16 End: 03/31/17 Due: 03/31/18

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

Phase: N/A Priority: Normal
NCT ID: NCT05682378 Org: User:
Start: 02/10/23 End: 03/02/28 Due: 03/02/29

Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients

Phase: N/A Priority: Normal
NCT ID: NCT04066244 Org: User:
Start: 12/30/19 End: 02/01/24 Due: 02/01/25

A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT02936102 Org: User:
Start: 10/20/16 End: 11/22/24 Due: 11/22/25

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT04328727 Org: User:
Start: 11/04/20 End: 12/06/24 Due: 12/06/25

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Phase: N/A Priority: Normal
NCT ID: NCT05266495 Org: User:
Start: 04/13/22 End: 03/13/23 Due: 03/13/24

A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01760525 Org: User:
Start: 03/20/13 End: 07/24/20 Due: 07/24/21

Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT02603393 Org: User:
Start: 11/20/15 End: 07/18/17 Due: 07/18/18

Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT01709838 Org: User:
Start: 12/06/12 End: 01/17/19 Due: 01/17/20

Letrozole in the Treatment of Severe and Recurrent Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT00240942 Org: User:
Start: 10/31/02 End: 06/30/06 Due: 06/30/07

Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00264160 Org: User:
Start: 05/31/06 End: 08/31/09 Due: 08/31/10

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05384587 Org: User:
Start: 11/11/22 End: 10/17/27 Due: 10/17/28

PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT03064854 Org: User:
Start: 05/24/17 End: 07/28/21 Due: 07/28/22

An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)

Phase: N/A Priority: Normal
NCT ID: NCT00787917 Org: User:
Start: 11/30/08 End: 07/31/10 Due: 07/31/11

A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT05524051 Org: User:
Start: 03/03/23 End: 06/19/25 Due: 06/19/26